Quantitative assessment of tumor metabolism using FDG-PET imaging.
about
Brain metabolism during hallucination-like auditory stimulation in schizophreniaCharacterization of PET/CT images using texture analysis: the past, the present… any future?Development of a nomogram combining clinical staging with (18)F-FDG PET/CT image features in non-small-cell lung cancer stage I-IIIStem cell transplantation in brain tumors: a new field for molecular imaging?Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivoComparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors.Monitoring chemotherapeutic response by hyperpolarized 13C-fumarate MRS and diffusion MRI.Biomarkers of cancer risk and therapeutic benefit: new technologies, new opportunities, and some challenges.Systems biology and the molecular circuits of cancer.Kinetic Modeling and Graphical Analysis of 18F-Fluoromethylcholine (FCho), 18F-Fluoroethyltyrosine (FET) and 18F-Fluorodeoxyglucose (FDG) PET for the Fiscrimination between High-Grade Glioma and Radiation Necrosis in Rats.Evaluation of 18-F-fluoro-2-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) as a staging and monitoring tool for dogs with stage-2 splenic hemangiosarcoma - A pilot study.The Potential of Metabolic Imaging.Impaired mitochondrial metabolism and mammary carcinogenesisThe role of clinical imaging in oncological drug development.Prognostic value of metabolic tumor burden in lung cancer.Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma.Independent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer.Tumor RNA disruption predicts survival benefit from breast cancer chemotherapy.Hyperpolarized Sodium [1-13C]-Glycerate as a Probe for Assessing Glycolysis In Vivo.Simultaneous PET/MRI assessment of response to cytotoxic and hormone neo-adjuvant chemotherapy in breast cancer: a preliminary report.Imaging of Tumor Metabolism Using Positron Emission Tomography (PET).Metabolic reprogramming in clear cell renal cell carcinoma.Wavelet denoising in voxel-based parametric estimation of small animal PET images: a systematic evaluation of spatial constraints and noise reduction algorithms.Quantitation of glucose uptake in tumors by dynamic FDG-PET has less glucose bias and lower variability when adjusted for partial saturation of glucose transport.Dual energy CT for attenuation correction with PET/CTUsing FDG-PET activity as a surrogate for tumor cell density and its effect on equivalent uniform dose calculation.Towards enhanced PET quantification in clinical oncology.Can Laws Be a Potential PET Image Texture Analysis Approach for Evaluation of Tumor Heterogeneity and Histopathological Characteristics in NSCLC?Total lesion glycolysis as an IgG4-related disease activity marker.Metabolomics and Metabolic Reprogramming in Kidney Cancer.
P2860
Q30444568-B4829F2A-3A76-4DA6-865D-B4998FDEF22DQ30837034-D2628642-17E0-4BAE-8071-C316E6155E2EQ33617538-11A13262-E980-4AF3-857F-18170008BA70Q33622514-6F722200-5661-43B5-BC93-B2AC03753220Q35606075-AA267C54-BD04-46D2-8A45-E5DD48DCD8DBQ35661959-688226AB-B422-49FE-830A-E2C93F54837CQ35703167-14A2ABCA-AF3E-4296-8255-C0683B9DB648Q35812523-12794DBD-D370-4239-B6AC-76FD4644F552Q35905281-636C2285-6895-48E2-8A9B-2BCCC7700FD5Q36112565-0822600B-A1AD-43A3-A5D0-D35D0DF90CBAQ36286330-27D26752-3F1D-4A63-B619-F58FAE856F48Q36392626-4BBAC178-E627-4FCD-8EBE-4EEFFE8EBEC9Q36636779-61B57A18-A6CD-488D-86DC-9B24F2FB444BQ37187098-702C1672-C893-4482-A519-CB8FB965640BQ37413672-83E1E072-4189-41C1-B69B-72405D8F12FAQ37697049-321890E0-0428-4C74-8BCC-1F10E06E2B3DQ38014317-6CA0789A-CBEC-40C1-BF88-A7F347C50B95Q38407471-645F7096-87F8-4550-82A9-9EBF06122A09Q38688183-F521F791-A778-4FB7-B027-91B9B77A01C8Q38776345-8FB4B40A-E91D-4D2C-AF50-22104239C33FQ38936273-4B6595B7-56ED-44CC-9D8A-F7EAB9F51170Q39290307-2D9066E3-C65F-4704-82A6-1B6C3E19CDD2Q41833802-90E8CB14-2062-487B-BEFA-6B54938930F3Q41858745-87ADDA1E-2433-4B45-B500-A65F60AE4CB3Q42051213-24D851D5-0D38-476E-A338-87309E3D9F1CQ45109147-3A4A2076-9B69-44FA-94BD-F414D1B13E98Q47823973-8ABFCD8C-2DA1-4928-99D3-76A501E777E1Q47950798-18037229-4E9D-4996-852F-38BD9CF2C215Q50608230-10E93C35-40DC-41F4-9DDD-8B51143090A4Q52618376-7F161543-1637-4722-A929-AA7FF2744432
P2860
Quantitative assessment of tumor metabolism using FDG-PET imaging.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Quantitative assessment of tumor metabolism using FDG-PET imaging.
@ast
Quantitative assessment of tumor metabolism using FDG-PET imaging.
@en
Quantitative assessment of tumor metabolism using FDG-PET imaging.
@nl
type
label
Quantitative assessment of tumor metabolism using FDG-PET imaging.
@ast
Quantitative assessment of tumor metabolism using FDG-PET imaging.
@en
Quantitative assessment of tumor metabolism using FDG-PET imaging.
@nl
prefLabel
Quantitative assessment of tumor metabolism using FDG-PET imaging.
@ast
Quantitative assessment of tumor metabolism using FDG-PET imaging.
@en
Quantitative assessment of tumor metabolism using FDG-PET imaging.
@nl
P2093
P1476
Quantitative assessment of tumor metabolism using FDG-PET imaging.
@en
P2093
P304
P356
10.1016/S0969-8051(00)00141-4
P577
2000-10-01T00:00:00Z